Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity
Open accessPublished version of a preprint
Abstract
The cellular prion protein PrP C mediates the neurotoxicity of prions and other protein aggregates through poorly understood mechanisms. Antibody‐derived ligands against the globular domain of PrP C (GDL) can also initiate neurotoxicity by inducing an intramolecular R 208 ‐H 140 hydrogen bond (“H‐latch”) between the α2‐α3 and β2‐α2 loops of PrP C . Importantly, GDL that suppresses the H‐latch prolong the life of prion‐infected mice, suggesting that GDL toxicity and prion infections exploit convergent pathways. To define the structural underpinnings of these phenomena, we transduced 19 individual PrP C variants to PrP C ‐deficient cerebellar organotypic cultured slices using adenovirus‐associated viral vectors (AAV). We report that GDL toxicity requires a single N‐proximal cationic residue (K 27 or R 27 ) within PrP C . Alanine substitution of K 27 also prevented the toxicity of PrP C mutants that induce Shmerling syndrome, a neurodegenerative disease that is suppressed by co‐expression of wild‐type PrP C . K 27 may represent an actionable target for compounds aimed at preventing prion‐related neurodegeneration.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764 · see citing works
Synthetic amyloid-β oligomers impair long-term memory independently of cellular prion protein
Balducci, C., Beeg, M., Stravalaci, M., Bastone, A., Sclip, A., Biasini, E., Tapella, L., Colombo, L., Manzoni, C., Borsello, T., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911829107 · Cited by 466 · cited 1× · see citing works
“Several studies have reported a high-affinity interaction of the CC2 with amyloid-β (Aβ) oligomers [8, 33].”
BackgroundZhang, H., Yang, B., Mu, X., Ahmed, S. S., Su, Q., He, R., Wang, H., Mueller, C., Sena-Esteves, M., Brown, R., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2011.98 · Cited by 291 · see citing works
Flagged first, then by citations
- Authors
- Reimann, R. R., Puzio, M., Rosati, A., Emmenegger, M., Schneider, B. L., Valdés, P., Huang, D., Caflisch, A., & Aguzzi, A.
- Affiliations
- University of Zurich (CH)
- École Polytechnique Fédérale de Lausanne (CH)
- Department of Biochemistry University of Zürich Zürich Switzerland
- Corresponding author
- Reimann, Regina R.
- Aguzzi, Adriano
- ORCID
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2022-11-03
- Volume
- 33
- Issue
- 2
- Pages
- e13130-e13130
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- PMC
- PMC10041163
- OpenAlex
- W4308182087
- Cited by
- 3
- References
- 3
- Citations by year
- 2025: 2 · 2023: 1
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Brain Pathology (publishedVersion, cc-by-nc-nd)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Human Frontier Science Program (ID RGP0001/2022)
- Michael J. Fox Foundation (ID MJFF‐022156)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (ID 179040, ID 207872, ID 183563)
- Stavros Niarchos Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- cellular prion protein, intramolecular hydrogen bonding, neurotoxicity, cationic residues, prion infection, neurodegeneration
- MeSH terms
- Prion Proteins, Animals, Antibodies, Prions, Prion Diseases, Neurodegenerative Diseases, Mice, Reverse Genetics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review